Patents by Inventor Farshid ALEMDEHY

Farshid ALEMDEHY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES BINDING TO CD30 AND CD3
    Publication number: 20240132607
    Abstract: The invention relates to multispecific antibodies binding to CD3 and CD30. The invention further provides pharmaceutical compositions comprising antibodies of the invention, nucleic acids encoding the antibodies, host cells that produce the antibodies, methods of producing the antibodies and uses of the antibodies, in particular for cancer therapy.
    Type: Application
    Filed: September 28, 2023
    Publication date: April 25, 2024
    Inventors: David SATIJN, Patrick ENGELBERTS, Kristel KEMPER, Esther C. W. BREIJ, Simone OOSTINDIE, Farshid ALEMDEHY
  • Antibodies binding to CD30 and CD3
    Patent number: 11814437
    Abstract: The invention relates to multispecific antibodies binding to CD3 and CD30. The invention further provides pharmaceutical compositions comprising antibodies of the invention, nucleic acids encoding the antibodies, host cells that produce the antibodies, methods of producing the antibodies and uses of the antibodies, in particular for cancer therapy.
    Type: Grant
    Filed: October 6, 2022
    Date of Patent: November 14, 2023
    Assignee: GENMAB A/S
    Inventors: David Satijn, Patrick Engelberts, Kristel Kemper, Esther C. W. Breij, Simone Oostindie, Farshid Alemdehy
  • miRNA-193a for Promoting Immunogenic Cell Death
    Publication number: 20230136088
    Abstract: The invention relates to the use of miRNA-193a for regulating gene expression, particularly it relates to the use of miRNA-193a as a CRT agonist, promoting the cell surface expression of CRT. This allows the advantageous treatment of cancers without or with low surface expression of CRT. The invention further relates to compositions comprising the miRNA for use in such treatment.
    Type: Application
    Filed: February 26, 2021
    Publication date: May 4, 2023
    Applicant: INTERNA TECHNOLOGIES B.V.
    Inventors: Sanaz YAHYANEJAD, Bryony TELFORD, Marion VAN DEN BOSCH, Mir Farshid ALEMDEHY, Matheus Maria DE GUNST, Laurens Adrianus Hendricus VAN PINXTEREN, Roeland Quirinus Jozef SCHAAPVELD, Michel JANICOT
  • ANTIBODIES BINDING TO CD30 AND CD3
    Publication number: 20230132049
    Abstract: The invention relates to multispecific antibodies binding to CD3 and CD30. The invention further provides pharmaceutical compositions comprising antibodies of the invention, nucleic acids encoding the antibodies, host cells that produce the antibodies, methods of producing the antibodies and uses of the antibodies, in particular for cancer therapy.
    Type: Application
    Filed: October 6, 2022
    Publication date: April 27, 2023
    Inventors: David SATIJN, Patrick Engelberts, Kristel Kemper, Esther C.W. Breij, Simone OOSTINDIE, Farshid ALEMDEHY
  • NEW TREATMENTS INVOLVING MIRNA-193A
    Publication number: 20220275368
    Abstract: The invention relates to the use of miRNA-193a for regulating gene expression, particularly it relates to the use of miRNA-193a as a PTEN agonist. This allows the advantageous treatment of PTEN-deficient cancers. The invention further relates to compositions comprising the miRNA for use as a PTEN agonist.
    Type: Application
    Filed: March 6, 2020
    Publication date: September 1, 2022
    Applicant: INTERNA TECHNOLOGIES B.V.
    Inventors: Sanaz YAHYANEJAD, Bryony Jane TELFORD, Marion Tina Jolien VAN DEN BOSCH, Mir Farshid ALEMDEHY, Matheus Maria DE GUNST, Laurens Adrianus Hendricus VAN PINXTEREN, Roeland Quirinus Jozef SCHAAPVELD, Michel JANICOT